These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16548244)

  • 21. Current concepts on monoclonal gammopathies.
    Flecknoe-Brown S
    Aust N Z J Med; 1992 Dec; 22(6):703. PubMed ID: 1489297
    [No Abstract]   [Full Text] [Related]  

  • 22. [Paraproteinemia in a case of "hyperIgE" syndrome in pediatric age. Preliminary observations].
    Cingolani M; Moni L; Bonioli E; Di Stefano A; Fortini P; Gemme G
    Minerva Pediatr; 1983 Feb; 35(4):181-92. PubMed ID: 6855718
    [No Abstract]   [Full Text] [Related]  

  • 23. [Advantages of the combination of the technics of double arc precipitation analysis and of scaled dilutions in the study of asymptomatic monoclonal gammopathies].
    Scrobogna S; Novello E; Tommasini T; Bernard G
    Quad Sclavo Diagn; 1977 Dec; 13(4):504-12. PubMed ID: 614610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal gammopathies--their identification and biological significance.
    Osterland CK
    Clin Chim Acta; 1989 Mar; 180(1):1-22. PubMed ID: 2663237
    [No Abstract]   [Full Text] [Related]  

  • 25. [Principles of the immunochemical analysis in diagnosis of paraproteinemias].
    Chernokhvostova EV; Batalova TN; German GP
    Ter Arkh; 1977; 49(8):68-76. PubMed ID: 412264
    [No Abstract]   [Full Text] [Related]  

  • 26. [Monoclonal gammopathies].
    Fain O
    Rev Prat; 2006 Jan; 56(1):40-50. PubMed ID: 16548248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral neuropathies associated with monoclonal gammopathies of undetermined significance.
    Kelly JJ
    Rev Neurol Dis; 2008; 5(1):14-22. PubMed ID: 18418318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel extended reference range for serum kappa/lambda free light chain ratio in diagnosing monoclonal gammopathies in renal insufficient patients.
    Diamantidis MD; Ioannidou-Papagiannaki E; Ntaios G
    Clin Biochem; 2009 Jul; 42(10-11):1202-3. PubMed ID: 19375413
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunoelectrophoresis--indications and clinical relevance].
    Kühn RA
    Z Gesamte Inn Med; 1982 Oct; 37(19):666-8. PubMed ID: 7180066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Light chains, casts, sheets and fibrils: monoclonal immunoglobulin diseases and immunotactoid/fibrillary glomerulopathy.
    Dember LM
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1320-1. PubMed ID: 17699364
    [No Abstract]   [Full Text] [Related]  

  • 31. [Neuropathy, monoclonal gammopathy and autoantibodies: how to establish a link?].
    Stojkovic T
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S45-53. PubMed ID: 18087229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of the analytical performance and the sensitivity of serum free light chains immunoassay in patients with monoclonal gammopathy.
    Wolff F; Thiry C; Willems D
    Clin Biochem; 2007 Mar; 40(5-6):351-4. PubMed ID: 17239359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum free light chain assay reduces the need for serum and urine immunofixation electrophoresis in the evaluation of monoclonal gammopathy.
    Fulton RB; Fernando SL
    Ann Clin Biochem; 2009 Sep; 46(Pt 5):407-12. PubMed ID: 19641008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunophenotypic approach to the identification and characterization of clonal plasma cells from patients with monoclonal gammopathies.
    Pérez-Andrés M; Santiago M; Almeida J; Mateo G; Porwit-MacDonald A; Bjorklund E; Valet G; Kraan J; Gratama JW; D'Hautcourt JL; Merle-Beral H; Lima M; Montalban MA; San Miguel JF; Orfao I; ;
    J Biol Regul Homeost Agents; 2004; 18(3-4):392-8. PubMed ID: 15786710
    [No Abstract]   [Full Text] [Related]  

  • 35. Performance of the Sebia CAPILLARYS 2 for detection and immunotyping of serum monoclonal paraproteins.
    Yang Z; Harrison K; Park YA; Chaffin CH; Thigpen B; Easley PL; Smith JA; Robinson CA; Lorenz RG; Hardy RW
    Am J Clin Pathol; 2007 Aug; 128(2):293-9. PubMed ID: 17638665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Light chains: heavy burden in kidney transplantation.
    Heher EC; Spitzer TR; Goes NB
    Transplantation; 2009 Apr; 87(7):947-52. PubMed ID: 19352111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID monoclonal antibody therapy detected by serum immunofixation electrophoresis.
    Shaver AC; Mason EF
    Blood; 2022 Aug; 140(5):521. PubMed ID: 35925640
    [No Abstract]   [Full Text] [Related]  

  • 38. [Detection of free light chains--a new method of diagnostics of haematological diseases].
    Mecl J; Benáková H; Nohejlová A; Straub J; Zima T; Spicka I
    Cas Lek Cesk; 2007; 146(2):159-62. PubMed ID: 17373113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IgD idiopathic paraproteinemia in the aging C57BL/KaLwRij mouse.
    Radl J; Van den Berg P; Jol-van der Zijde CM
    J Immunol; 1980 May; 124(5):2513-5. PubMed ID: 7365265
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of pore-gradient polyacrylamide electrophoresis in the diagnosis of paraproteinemias].
    Kopperschläger G; Storch H; Birkenmeier G
    Z Med Lab Diagn; 1977; 18(5):300-8. PubMed ID: 595779
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.